ANI PHARMACEUTICALS, INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
ANI PHARMACEUTICALS, INC (ANIP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 28.00 thousand shares for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-05.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2015-05-05
- ANI PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2015-03-31 was 28.00K shares.
- ANI PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2014-03-31 was 0.00 shares.
- ANI PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2014 was 4.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|
| 2015-03-31 | 28.00K shares 10-Q · filed 2015-05-05 | |
| 2014-12-31 | 4.00K shares 10-K · filed 2015-02-23 | |
| 2014-03-31 | 0.00 shares 10-Q · filed 2015-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |